Author:
Heinsar Silver,Jung Jae-Seung,Colombo Sebastiano Maria,Rozencwajg Sacha,Wildi Karin,Sato Kei,Ainola Carmen,Wang Xiaomeng,Abbate Gabriella,Sato Noriko,Dyer Wayne Bruce,Livingstone Samantha Annie,Pimenta Leticia Pretti,Bartnikowski Nicole,Bouquet Mahe Jeannine Patricia,Passmore Margaret,Vidal Bruno,Palmieri Chiara,Reid Janice D.,Haqqani Haris M.,McGuire Daniel,Wilson Emily Susan,Rätsep Indrek,Lorusso Roberto,Suen Jacky Y.,Bassi Gianluigi Li,Fraser John F.
Abstract
AbstractRefractory cardiogenic shock (CS) often requires veno-arterial extracorporeal membrane oxygenation (VA-ECMO) to sustain end-organ perfusion. Current animal models result in heterogenous cardiac injury and frequent episodes of refractory ventricular fibrillation. Thus, we aimed to develop an innovative, clinically relevant, and titratable model of severe cardiopulmonary failure. Six sheep (60 ± 6 kg) were anaesthetized and mechanically ventilated. VA-ECMO was commenced and CS was induced through intramyocardial injections of ethanol. Then, hypoxemic/hypercapnic pulmonary failure was achieved, through substantial decrease in ventilatory support. Echocardiography was used to compute left ventricular fractional area change (LVFAC) and cardiac Troponin I (cTnI) was quantified. After 5 h, the animals were euthanised and the heart was retrieved for histological evaluations. Ethanol (58 ± 23 mL) successfully induced CS in all animals. cTnI levels increased near 5000-fold. CS was confirmed by a drop in systolic blood pressure to 67 ± 14 mmHg, while lactate increased to 4.7 ± 0.9 mmol/L and LVFAC decreased to 16 ± 7%. Myocardial samples corroborated extensive cellular necrosis and inflammatory infiltrates. In conclusion, we present an innovative ovine model of severe cardiopulmonary failure in animals on VA-ECMO. This model could be essential to further characterize CS and develop future treatments.
Funder
The Prince Charles Hospital Foundation, Australia
National Health and Medical Research Council (Australia) Centre for Research Excellence in Advanced Cardiorespiratory Therapies Improving OrgaN Support
Publisher
Springer Science and Business Media LLC
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献